Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 71 of the 75 references it cites were found in a registry or an index; 12 of the 43 sources its claims cite were checked for support.

Mesenchymal Stem Cells for Enhanced Healing of the Medial Collateral Ligament of the Knee Joint

Open access

Abstract

: The medial collateral ligament (MCL) is one of the major supporting ligaments of the knee joint, and MCL injuries are common where excessive valgus loading is applied to the knee joint. Although most MCL injuries can be treated conservatively, healing of the MCL can take several weeks to months. Furthermore, once injured, the biomechanical properties of the healed MCL differ from those of the native MCL, resulting in an increased risk of re-injury and chronic remnant symptoms. Mesenchymal stem cells (MSCs), owing to their therapeutic potential, have been investigated in various musculoskeletal injuries, and some preclinical studies regarding MSC-based approaches in MCL injuries have shown promising results. Despite satisfactory results in preclinical studies, there is still a lack of clinical studies in the orthopedic literature. This article describes the basic knowledge of the MCL, standard treatments for MCL injuries, and recent studies regarding the application of MSCs for enhanced healing of the MCL. MSC-based approaches are expected to be a potential therapeutic option for enhanced healing of the MCL in the future.

Overview

CoChat Summary

TL;DR

This is a narrative review of medial collateral ligament (MCL) anatomy, biomechanics, standard treatment, and preclinical mesenchymal stem cell (MSC) approaches for enhanced healing. The paper concludes that MSC-based therapies look promising in animal studies, but clinical evidence is still lacking.

Key findings

  • The MCL is described as the knee’s most frequently injured ligament, accounting for up to 40% of all knee ligament injuries and 7.9% of all knee injuries in a 10-year athletic study.
  • The review identifies six preclinical studies of MSC use for MCL healing, and states that these studies have been conducted since 2002 in animal models only.
  • Reported preclinical benefits included improved neovascularization, histology, and biomechanics; for example, in one rat study, CD34+ cells increased UEA-1+/HLA-ABC+ cells to 119.5 ± 20.0 vs 54.0 ± 16.5 in MNC and 0.0 ± 0.0 in controls, with capillary profiles of 301.0 ± 18.1 vs 209.5 ± 32.3 and 108.6 ± 15.6.
  • The paper notes dose dependence in MSC effects: in one rat model, a low dose (1 × 10⁶ cells) produced better functional outcomes than a high dose (4 × 10⁶ cells), including increased failure strength and stiffness by day 14.

Methods

  • Narrative review article synthesizing basic science, treatment, and preclinical literature on MCL injury and MSC-based healing.
  • The paper’s own review found six studies of MSCs for MCL healing, all in preclinical animal model settings.
  • Analysis is descriptive and chronological, summarizing reported anatomy, biomechanics, treatment approaches, and outcomes from the included studies.

Limitations

  • The paper explicitly states that the literature is limited to preclinical animal studies, with a lack of clinical evidence.
  • It also states that the precise mechanism by which MSCs enhance MCL healing is still unknown and that research on cell source, cell dosage, and reproducible preparation process is still in its infancy.
  • Evident from the text: the review does not report a systematic search strategy or formal quality assessment of the included studies.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/medicina59040725

Cites

71 of 71 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Anatomy of the medial collateral ligament (white arrows) and its surrounding structures.
Figure 1 Anatomy of the medial collateral ligament (white arrows) and its surrounding structures.CC BY · PubMed Central

Verification

Claims the paper makes

10 Valid · 2 Not valid · 15 Not checked · 8 Own results and interpretations

8 more claims

Create a free account to see all 35 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 8
  • It may state two separate claims as one. 14
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Citations

Cites

Show all 75 references

Cited by

See all 7

Metadata

Authors
Lee, C.-S., Jeon, O.-H., Han, S.-B., & Jang, K.-M.
Affiliations
Korea University (KR)
Corresponding author
Jang, Ki-Mo
Venue
Medicina
Publisher
MDPI AG
Published
2023-04-07
Volume
59
Issue
4
Pages
725
ISSN
  • 1010-660X (ISSN-L)
  • 1648-9144
OpenAlex
W4363675706
Cited by
7
References
75
Citations by year
2026: 2 · 2025: 2 · 2024: 1 · 2023: 2
FWCI
0.45
Type
journal article
Language
en
Open access
Locations
  • Medicina (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Ministry of Trade, Industry & Energy (20003688)
Topics
  • Health Sciences › Medicine › Surgery › Knee injuries and reconstruction techniques
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Tendon Structure and Treatment
Keywords
mesenchymal stem cells, medial collateral ligament, knee joint, ligament healing, valgus loading, stem cell therapy, ligament reconstruction
MeSH terms
Anterior Cruciate Ligament Injuries, Humans, Knee Joint, Wound Healing, Collateral Ligaments, Mesenchymal Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mesenchymal Stem Cells for Enhanced Healing of the Medial Collateral Ligament of the Knee Joint. https://app.cochat.ai/papers/10.3390/medicina59040725
The paper
Lee, C.-S., Jeon, O.-H., Han, S.-B., & Jang, K.-M. (2023). Mesenchymal Stem Cells for Enhanced Healing of the Medial Collateral Ligament of the Knee Joint. Medicina. https://doi.org/10.3390/medicina59040725

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.